SensoTech and SchuF Introduce a Combination Valve and Sensor for Real-Time Process Analysis - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

SensoTech and SchuF Introduce a Combination Valve and Sensor for Real-Time Process Analysis
A bottom-outlet valve with combined sensor is a new process analytical technology tool.

Equipment and Processing Report

A challenge for process analytical technology is finding suitable entry points in reactors to analyze reactions in real time. SensoTech and valve manufacturer SchuF developed MultiProbe, a bottom outlet valve combined with SensoTech’s LiquiSonic sensor, to enable process analysis even in low-volume batches without additional process adapters.  LiquiSonic systems consist of one or more sensors and a controller that records measurements and transfers them to the process control system. The system provides precise data about concentration and density in liquids, detects phase transitions, and monitors reactions.

Source: SensoTech

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What impact do mega-mergers of biopharmaceutical companies have on the development of new drugs?
Improves the quality and number of innovative drugs available to patients.
Restricts innovation and the development of new drugs.
Has no impact on drug development.
Do not know.
Improves the quality and number of innovative drugs available to patients.
29%
Restricts innovation and the development of new drugs.
54%
Has no impact on drug development.
4%
Do not know.
13%
Eric Langer Outsourcing Outlook Eric LangerOutsourcing No Longer Just for Cost-Cutting
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerSeeking Alternative Catalyst Solutions
Jill Wechsler Regulatory Watch Jill Wechsler Global Expansion Shapes Drug Oversight
Chris Burgess Statistical Solutions Chris BurgessIs a Sample Size of n=6 a Magic Number?
Sean Milmo European Regulatory WatchSean MilmoRegulating the Environmental Impact of Pharmaceuticals
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
USP Faces New Challenges
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Source: Equipment and Processing Report,
Click here